Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 475 of 984 entries
View as:

A Study of Vedolizumab and Biologic Agents in Participants With Inflammatory Bowel Disease (IBD)

Phase: N/A Priority: Normal
NCT ID: NCT05596422 Org: User:
Start: 05/27/21 End: 12/08/22 Due: 12/08/23

Effect of Food on the Pharmacokinetics of Single Oral Dose Administration of a Fixed-Dose Combination of SYR-322 and Metformin Hydrochloride in Healthy Adult Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02276274 Org: User:
Start: 06/30/14 End: 06/30/14 Due: 06/30/15

A Study of TAK-536 in Children From 2 to Less Than 6 Years Old With High Blood Pressure

Phase: N/A Priority: Normal
NCT ID: NCT04668157 Org: User:
Start: 05/17/21 End: 12/28/23 Due: 12/28/24

A Chart Review Study of Adults With Advanced NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT05207423 Org: User:
Start: 10/03/22 End: 02/13/23 Due: 02/13/24

A Study of Chinese Adults With Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT05288491 Org: User:
Start: 10/31/22 End: 06/20/24 Due: 06/20/25

A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability of TAK-123 After Intravenous Infusion in Japanese Healthy Adult Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT04155567 Org: User:
Start: 11/13/19 End: 12/06/19 Due: 12/06/20

A Proof-of-concept Study to Reduce Treatment Burden in Haemophilia Participants Receiving Factor VIII and Factor IX Infusions

Phase: N/A Priority: Normal
NCT ID: NCT05437211 Org: User:
Start: 06/23/23 End: 02/21/24 Due: 02/21/25

A Single Heterologous Booster Vaccination Study of TAK-019 in Healthy Japanese Adults (COVID-19)

Phase: N/A Priority: Normal
NCT ID: NCT05299359 Org: User:
Start: 04/15/22 End: 10/18/23 Due: 10/18/24

Study of TAK-071 in Healthy Participants and Participants With Mild Cognitive Impairment/Mild Alzheimer Disease and Relative Bioavailability (BA) and Food Effect of TAK-071 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT02769065 Org: User:
Start: 05/05/16 End: 06/08/17 Due: 06/08/18

Efficacy and Safety of Vedolizumab Subcutaneously (SC) as Maintenance Therapy in Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT02611830 Org: User:
Start: 12/18/15 End: 08/21/18 Due: 08/21/19

Behavioral and Subjective Efficacy of Ramelteon in Subjects With a History of Polydrug Abuse

Phase: N/A Priority: Normal
NCT ID: NCT00671632 Org: User:
Start: 06/30/03 End: 12/31/03 Due: 12/31/04

A Study of Azilsartan in Children from 6 to Less Than 16 Years Old with High Blood Pressure

Phase: N/A Priority: Normal
NCT ID: NCT05107960 Org: User:
Start: 12/16/21 End: 08/31/24 Due: 08/31/25

A Study of Ixazomib Plus Lenalidomide and Dexamethasone in Adult Japanese Participants With Relapsed and/or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT02917941 Org: User:
Start: 11/01/16 End: 08/31/19 Due: 08/31/20

Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules in Treating Symptomatic Non-Erosive Gastroesophageal Reflux Disease in Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT01642602 Org: User:
Start: 07/31/12 End: 01/31/14 Due: 01/31/15

Phase 1 TAK-915 Single-Dose Positron Emission Tomography (PET) Occupancy Study

Phase: N/A Priority: Normal
NCT ID: NCT02584569 Org: User:
Start: 11/30/15 End: 04/30/16 Due: 04/30/17

Safety and Tolerability of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00707980 Org: User:
Start: 06/30/08 End: 08/31/10 Due: 08/31/11

Roflumilast Plus Antipsychotics Proof of Mechanism Study in Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT02079844 Org: User:
Start: 03/31/14 End: 06/30/15 Due: 06/30/16

Study of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00762190 Org: User:
Start: 11/30/03 End: 12/31/04 Due: 12/31/05

A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT06973291 Org: User:
Start: 07/11/25 End: 07/03/26 Due: 07/03/27

A Study of Mobocertinib in Japanese Adults With Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03807778 Org: User:
Start: 02/04/19 End: 09/30/26 Due: 09/30/27

Efficacy of Lapaquistat Acetate and Atorvastatin on Blood Cholesterol Levels in Subjects With Primary Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT00143676 Org: User:
Start: 08/31/05 End: 08/31/06 Due: 08/31/07

A Phase 3, Long-term, Extension Study of TVP-1012 (1 mg) in Early Parkinson's Disease Participants

Phase: N/A Priority: Normal
NCT ID: NCT02337751 Org: User:
Start: 07/10/15 End: 03/14/17 Due: 03/14/18

Leuplin SR 11.25 mg Injection Kit Specified Drug-use Survey: "QOL Survey in Premenopausal Breast Cancer Patients"

Phase: N/A Priority: Normal
NCT ID: NCT02134977 Org: User:
Start: 09/30/11 End: 03/31/15 Due: 03/31/16

Agrylin Drug Use-Result Survey

Phase: N/A Priority: Normal
NCT ID: NCT03625895 Org: User:
Start: 11/25/14 End: 03/11/21 Due: 03/11/22

Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-339)

Phase: N/A Priority: Normal
NCT ID: NCT00163306 Org: User:
Start: 05/31/05 End: - Due: -